Feb 12, 2003 | NEWS
deCODE enlisted to carry out the latest stage in one of the most aggressive drug development drives ever undertaken by a family-based patients’ organization Reykjavik, ICELAND, and Libertyville, ILLINOIS, February 12, 2003 — deCODE genetics (Nasdaq/Nasdaq Europe:DCGN)...
Dec 13, 2002 | NEWS
Reykjavik, ICELAND, December 13, 2002 — deCODE genetics (Nasdaq/Nasdaq Europe:DCGN) announced today that team of deCODE scientists has mapped to a small segment of chromosome 16 a gene contributing to psoriatic arthritis. This represents the first genetic factor...
Dec 13, 2002 | NEWS
Reykjavik, ICELAND, December 13, 2002 — deCODE genetics (Nasdaq/Nasdaq Europe:DCGN) announced today that a large association study carried out by its scientists and colleagues in Scotland has confirmed the significant link between the Neuregulin 1 gene and...
Nov 20, 2002 | NEWS
deCODE will apply its expertise in in vitro pharmacogenomics to provide gene expression data in relation to a Wyeth candidate treatment for respiratory disease Reykjavik, ICELAND, November 20, 2002 — deCODE genetics (Nasdaq/Nasdaq Europe:DCGN) today announced the...
Nov 11, 2002 | NEWS
Highlights deCODE’s capabilities in structural biology and x-ray protein crystallography; may enable design of more effective anti-cancer compounds Reykjavik, ICELAND, November 11, 2002 — deCODE genetics (Nasdaq/Nasdaq Europe:DCGN) today announced that scientists from...
Sep 27, 2002 | NEWS
Alliance brings together world-leading capabilities in genetics and drug development to speed the discovery of new treatments Reykjavik, ICELAND, September 27, 2002 — deCODE genetics (Nasdaq/Nasdaq Europe:DCGN) and Merck & Co., Inc. (NYSE:MRK) today announced the...
